FDA advisers endorse Merck's COVID antiviral drug in narrow vote
CBSN
A panel of the Food and Drug Administration's outside drug advisers voted narrowly Tuesday to endorse allowing antiviral pills developed by Merck and Ridgeback Biotherapeutics to be prescribed for COVID-19, following an hours-long meeting mulling the benefits and risks of molnupiravir to treat the disease in high-risk adults.
While not binding, the vote by the FDA's Antimicrobial Drugs Advisory Committee could clear the way for the agency to grant emergency use authorization for adults, as the United Kingdom has already done. Some 3.1 million courses of Merck's five-day treatment have been purchased for distribution by the Biden administration, if the pill is greenlighted.
"I voted yes because COVID-19 is still an emergency situation," Dr. W. David Hardy, a scientist at Charles Drew University School of Medicine and Science and one of the committee members, said following the vote.
Washington — The Supreme Court on Friday said it will consider the constitutionality of the Federal Communications Commission's Universal Service Fund, agreeing to review a lower court decision that upended the mechanism for funding programs that provide communications services to rural areas, low-income communities and schools, libraries and hospitals.
Jeff Bezos' Blue Origin launched six space tourists on a high-speed dash to the edge of space and back Friday, giving the passengers — including a husband and wife making their second flight — about three minutes of weightlessness and an out-of-this world view before the capsule made a parachute descent to touchdown at the company's west Texas flight facility.